Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Great Stocks To Watch This Week: ACHN, LMAT, NBIX, VUZI

Published 12/29/2015, 11:37 PM
Updated 07/09/2023, 06:31 AM

The markets had a big day on Tuesday. They gapped, ran, and had a really strong session until the last hour when profit taking set in, but it was a strong close. Most stocks we follow did well, and some new ones popped up, so let’s take a look at the ones we were trading today.

Achillion Pharmaceuticals Inc (O:ACHN) had a swing was put on it on Tuesday. This stock was a big winner for us after being down for almost a year. By Oct it finished its low, ran up from the 6 1/2 range all the way up to about 10 1/2, and then consolidated, pulled back, tested the 50, formed a new rising channel bottom, consolidated, and is moving up. On Tuesday it was up 37 cents to 10.42, or 3.68%, on 1.4 million shares. It’s right up against resistance, looks like it wants to explode, and has a shot at taking out the 11-11.10 range near-term. When it gets through that level, it could head up toward 12 3/4 potentially. It has 8 3/4 days to cover.

LeMaitre Vascular Inc (O:LMAT) is on our Top 20 list for 2016, and continues to look great. The rising wedge was broken to the upside on Tuesday, up 1.08 to 17.77, or 6.5%, on 2.3 million shares. The volume wasn’t so good, but the OBV is looking great. Look for a move to 20 on this stock.

Neurocrine Biosciences Inc (O:NBIX) has been great all year. A swing was put on it in the high 30’s, and it ran up to 50 1/2. It tested the 50-dollar range four times, and in the last couple sessions it’s moved up. On Tuesday, it popped 3.48 to 56.49, or 6.6%, on a solid 6.8 million shares. That’s good volume for that stock. Watch the 58 1/2 level. If it can get through that, this stock could move substantially, maybe even to the low 70’s. It has 6 3/4 days to cover.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Vuzix Corp Cmn Stk (O:VUZI) has been doing great, particularly Tuesday when it popped 60 cents to 7.19, or 9%, on 535,800 shares traded. That’s the biggest volume since Jan. It's coming up towards the double top at the 7.40-.60 zone. If it gets through there, it could run to 8.00, and then 9-9 1/2. Those are the targets for VUZI. It’s looking good, with 7 days to cover.

Other stocks on the long side included Actinium Pharmaceuticals Inc (N:ATNM), Auris Medical Holding AG (O:EARS), Exelixis Inc (O:EXEL), Five9 Inc (O:FIVN), FXCM Inc (N:FXCM), Lattice Semiconductor Corporation (O:LSCC), NVIDIA Corporation (O:NVDA), ORBCOMM Inc (O:ORBC), Resource America Inc (O:REXI), and Vital Thera (O:VTL).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.